-+ 0.00%
-+ 0.00%
-+ 0.00%
FDA Grants Accelerated Approval To Etcamah For Advanced Breast Cancer With ESR1 Mutation; Authorizes Guardant360 CDx Assay As Companion Diagnostic For Breast Cancer
Share
Listen to the news

https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-new-breast-cancer-treatment

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending